Académique Documents
Professionnel Documents
Culture Documents
Slide 2: Erythrocytes
From the hematopoietic stem cell, the first cell type that commits to the red blood cell lineage is the BFU-E, or
burst-forming units-erythroid. This is not morphologically distinguishable, but its nature is known from in vitro
cell culture systems. The cell type that comes after is the CFU-E, or colony-forming units-erythroid, again not
identifiable morphologically, but is known from cell culture. Your book defines each cell type. One difference is
the number of cells they generate in a given time period. BFU-E tend to be more quiescent but have a larger
proliferative potential than CFU-E. Another difference is their sensitivity to early versus late-acting cytokines.
BFU-E are more responsive to the early acting cytokines IL-3 and GM-CSF, while CFU-E are more responsive to
erythropoietin, the renal hormone that drives erythrocyte production. CFU-E have more receptors to
transferrin, the main carrier protein for iron. Note that transferrin is not a cytokine. BFU-E and CFU-E are both
progenitor cells.
The generation of morphologically distinguishable cells, also called maturing cells, sets off a series of
differentiation that we will now look at on the next slide. But before we proceed, familiarize yourself with a few
more terms. The first one is erythroblast. Any morphologically identifiable red blood cell precursor in the bone
marrow that possesses a nucleus is an erythroblast. A normally differentiating erythroblast can also be called a
normoblast. A more advanced erythroblast differentiates into a reticulocyte, which has already pinched off its
nucleus. A reticulocyte then gives rise to a mature red blood cell, or erythrocyte.
Slide 3: Erythrocyte development
There are actually six morphologically defined stages of erythropoiesis. The first 4 stages are characterized by
the presence of a nucleus. The cells tend to decrease in size. Initially the nucleus takes up most of the cell, but
the nucleus-to-cytoplasm ratio decreases with differentiation. The nucleus also has a lacy appearance in the
beginning then turns more compact and darker over time. The cytoplasm is initially bluish, or basophilic, due to
RNA, then becomes pink or salmon color, or acidophilic, due to hemoglobin. The polychromatic normoblast is
the last mitotically activate erythroblast. In other words, from this stage on, the cells enter the Go phase and
are permanently quiescent. Also at this stage, hemoglobin production is at its peak. Overall, the normoblasts
spend up to 7 days in the bone marrow.
At the reticulocyte stage, the nucleus is gone, but there is residual RNA and mitochondria, which stain blue with
supravital stains such as methylene blue, as pointed by the horizontal arrow. They are still busy making
hemoglobin, but significantly less than the normoblasts. Reticulocytes may also contain iron granules, which are
identifiable by the stain Prussian blue. As such, they are referred to as siderocytes, whereas normoblasts with
iron deposits are referred to as sideroblasts. Compared to normoblasts, reticulocytes have a shorter time
period, about 2-3 days, before they differentiate to the next stage, which is the mature red blood cell. Many
reticulocytes leave the bone marrow into the peripheral blood before they mature. In certain conditions or
diseases, more reticulocytes spill out into the blood. Reticulocytes are forced out of the bone marrow earlier
than usual. These are called shift or stress reticulocytes. If you see polychromatophilic erythrocytes on a blood
smear, by using Romanowsky stain for example, these are most likely reticulocytes. In certain anemias that
cause a spillover of reticulocytes into circulation, the condition is known as polychromasia.
Slide 4: Erythropoietin
Under conditions of hypoxia, when tissues badly need oxygen, or in anemia, when there is blood loss, for
example, the production of erythropoietin, or EPO, in the kidney increases. EPO levels in the plasma are stable
as long as hemoglobin levels stay within the normal reference range. When hemoglobin goes below 12 g/dL,
however, EPO levels go up. EPO is the main cytokine driving erythroid maturation and proliferation. As I had
mentioned earlier, reticulocytes and their mature derivatives are mitotically inactive. That is, they cannot
respond to EPO. The liver contributes to some EPO. As you can see in this table, EPO has multiple effects, but
they all underlie erythrocyte production. It also shows here that EPO is set off by most anemic conditions, with
one exception. We will look at this in one of the modules concerning anemia.
Other hormones also have similar effects on erythropoiesis. They are testosterone, thyroid hormones, growth
hormone, and the hormones of the adrenal cortex, such as cortisol. Small surprise that some athletes
administer EPO and testosterone to boost their performance in endurance sports, such as the Tour de France.
Before we leave this section, let me point out a couple of limiting factors for erythropoiesis. One factor is iron
supply. In iron deficiency, the EPO effect can only go so far. However, with hemolytic anemia, enough iron is
reused from destroyed red blood cells. With anemia caused by hemorrhage or blood loss, erythropoiesis is
limited by iron stores, but without these stores, you can rescue the situation only by supplemental iron. Related
to this is the amount of iron-saturated transferrin. If this decreases, then erythropoiesis becomes limited. We
will discuss this in the anemia modules.